‘I Don’t Feel Like Myself’ — And There’s a Reason for That
It’s one of the most common things women say when they first sit down to talk about menopause: ‘I just don’t feel like myself.’ Not just physically — emotionally. Irritability that comes out of nowhere. Anxiety that’s become more intense or constant. A low-grade sadness that wasn’t there before. Difficulty finding joy in things that usually bring pleasure. For many women, these psychological changes are among the most disorienting and distressing aspects of the menopause transition.
And yet they’re often the least likely to be connected to menopause — by the women experiencing them, by family members, and sometimes even by healthcare providers who are more focused on physical symptoms. At our gynecology practice in Sugar Land and Missouri City, we address psychological wellbeing as a core component of menopause care, not an afterthought.
The Biological Basis of Mood Changes in Menopause
Mood changes during the menopause transition are not ‘just psychological’ — they have genuine, measurable biological underpinnings. Estrogen has direct effects on multiple neurotransmitter systems in the brain, including serotonin (involved in mood regulation and a target of antidepressants), dopamine (involved in motivation, reward, and executive function), norepinephrine (involved in arousal and anxiety), and GABA (the brain’s primary inhibitory neurotransmitter, involved in anxiety and sleep).
Progesterone’s metabolite allopregnanolone is a potent positive modulator of GABA-A receptors — essentially acting as a natural anti-anxiety and sedating agent. When progesterone falls during perimenopause, this GABA-modulating effect diminishes. Women who were previously sensitive to hormonal changes (those with a history of PMDD or postpartum depression) tend to be particularly vulnerable to the mood effects of perimenopausal progesterone fluctuations.
Estrogen also affects the density and sensitivity of serotonin receptors in the brain. Falling and fluctuating estrogen can disrupt serotonin signaling, contributing directly to depressive symptoms. This is one reason SSRIs and SNRIs (which enhance serotonin and norepinephrine signaling) have demonstrated effectiveness for both depression and vasomotor symptoms in menopausal women.
Perimenopause: The Highest-Risk Period for Depression
Research from the SWAN study and other longitudinal work has consistently shown that perimenopause — not postmenopause — is the period of highest risk for new-onset depression in women’s lives. Women without a prior history of depression have a two- to fourfold higher risk of developing a major depressive episode during perimenopause compared to premenopause. Women with a prior history of depression face an even higher risk.
This is important for two reasons. First, it means that perimenopausal depression is a neurobiologically distinct entity with specific hormonal drivers — it should not be treated identically to depression arising in younger adults in the absence of hormonal change. Second, it means that women (and their providers) should not be surprised when mood disorder symptoms emerge during perimenopause, even in women who have managed their mental health successfully for decades.
Anxiety in Perimenopause and Menopause
Generalized anxiety, panic attacks, and heightened stress reactivity are extremely common during the menopause transition and significantly underrecognized as menopause-related phenomena. Women who had previously manageable anxiety may find it substantially worsening in perimenopause. Some women experience panic attacks for the first time in their 40s and are understandably alarmed — especially because the physical symptoms of panic (racing heart, sweating, feelings of doom) can overlap with hot flashes.
The GABA-progesterone connection described above partially explains new-onset or worsened anxiety during perimenopause. Hormonal fluctuations that alter GABAergic tone in the brain can lower the threshold for anxiety responses. Sleep deprivation from night sweats further compounds anxiety, since chronic sleep deprivation is one of the strongest amplifiers of anxious mood. The experience of navigating unfamiliar, disruptive physical symptoms — while often receiving inadequate explanation from healthcare providers — adds a significant psychological stress load.
Distinguishing Menopause-Related Mood Changes From Mood Disorders
This is a clinical nuance that matters for treatment. Menopause-related mood symptoms exist on a spectrum. At one end are mood fluctuations that are clearly tied to hormonal cycling (feeling worse around periods, improving in the postmenopause) and are relatively mild. At the other end are full major depressive episodes or panic disorder that have emerged during the menopause transition but now have their own clinical momentum independent of hormonal status.
For mild, hormonally-entrained mood symptoms, treating the hormonal disruption — with hormone therapy or other menopause treatments — may be sufficient to restore emotional equilibrium. For moderate to severe depression or anxiety, or for mood symptoms that persist despite hormonal management, antidepressants or other psychiatric medications are indicated and effective. Cognitive-behavioral therapy (CBT) has excellent evidence for both depression and anxiety regardless of cause and should always be available as part of the treatment plan.
Treatment Approaches
Hormone therapy has evidence for improving mood in perimenopausal women — particularly in those with new-onset or worsened depressive symptoms that appear clearly related to the hormonal transition. The NAMS hormone therapy position statement acknowledges this, and several studies support estrogen’s antidepressant effect specifically in perimenopausal (not postmenopausal) women. For women who are appropriate candidates for HT and whose mood symptoms align closely with the hormonal transition, this is worth discussing with your gynecologist.
SSRIs and SNRIs (antidepressants) are effective for both depression and anxiety in menopausal women and have the additional benefit of reducing hot flash frequency — making them a useful dual-purpose choice for women with both psychological and vasomotor symptoms who are not using or prefer not to use hormone therapy. Paroxetine, venlafaxine, desvenlafaxine, and escitalopram all have evidence in this context. These are not addictive and can be used long-term safely with appropriate monitoring.
Cognitive-behavioral therapy (CBT) has Level I evidence from NAMS for menopause-related mood symptoms, hot flash-related distress, and sleep problems. It addresses the cognitive and behavioral components of mood and anxiety in ways that medication alone cannot. For women who prefer non-pharmacological approaches or want to address the psychological dimensions of the menopause transition comprehensively, CBT with a therapist experienced in women’s health is highly valuable.
Exercise is a genuine antidepressant — not a platitude. Meta-analyses consistently show that regular aerobic exercise has effects on depression comparable to antidepressant medication in mild to moderate depression, and synergistic effects when combined with medication in more severe cases. It also addresses anxiety, sleep, weight, cardiovascular risk, and bone health simultaneously — making it perhaps the single most broadly beneficial intervention available for perimenopausal and postmenopausal women.
When to Seek Help — And Why Sooner Is Better
If you’ve noticed significant mood changes, anxiety, or depressive symptoms in the context of the menopause transition, please don’t wait until things get much worse before seeking evaluation. Mood disorders are highly treatable, but the sooner they’re addressed, the shorter the period of suffering and functional impairment. There’s no virtue in waiting, and no reason to feel that psychological symptoms during menopause are less deserving of medical attention than physical ones.
Our gynecology team in Sugar Land and Missouri City incorporates mental health screening as part of routine menopause care. We use validated tools like the PHQ-9 and GAD-7 to assess depression and anxiety systematically, and we have connections to excellent mental health professionals in Fort Bend County when referral is appropriate. Your whole health — including your emotional wellbeing — matters to us.
